Woolly Mammoth De-Extinction Delayed: Colossal Biosciences Updates Timeline and Genetic Progress

The ambitious de-extinction timeline for the woolly mammoth has officially been pushed back, as Dallas-based biotechnology firm Colossal Biosciences grapples with a vastly more complex genetic landscape than initially anticipated. Originally slated for a first pregnancy target in 2027 and a birth by 2028, the resurrection of the iconic Ice Age herbivore is now projected for the early 2030s, according to company leadership.

Expanding the Genetic Blueprint Beyond Original Estimates

When Colossal Biosciences launched its high-profile de-extinction initiative in 2021, researchers estimated that successfully transforming an elephant cell nucleus into a mammoth-compatible blueprint would require editing approximately 60 genes. However, deeper sequencing and continuous genome analysis over the past year have revealed that the genetic lift is substantially heavier. That target number has now more than doubled to roughly 150 genes—and continues to rise.

This massive expansion in required edits stems from the intricate web of phenotypic traits necessary to survive a Pleistocene environment. Colossal scientists have successfully isolated regulatory switches responsible for shrinking the mammoth ear to roughly one-tenth the size of an Asian or African elephant’s ear. While modern elephants utilize massive, heavily vascularized ears as heat dumps to cool their blood in tropical climates, the woolly mammoth required extreme thermal conservation. Similar genetic markers have been mapped for the mammoth’s characteristically shorter tail, another vital adaptation for minimizing heat loss in sub-zero temperatures.

Furthermore, solving the puzzle of the mammoth’s legendary shaggy coat required overturning long-held biological assumptions. While conventional scientific wisdom held that elephants lacked sebaceous glands—the oil-secreting skin structures that keep mammalian hair supple and prevent breakage—close anatomical dissection of elephant skin samples proved otherwise. Researchers discovered small, rudimentary sebaceous structures. The current challenge involves isolating and engineering the specific genes required to fully develop these glands in an engineered hybrid.

From Woolly Mice to Mammalian Milestones

Testing these complex genomic alterations requires stepping stones before moving to larger species. In March 2025, Colossal researchers unveiled a brood of 38 woolly mice engineered with mammoth coding for thick, coarse hair embedded directly into their genome. These mice have successfully thrived and bred, passing their distinct coats down to their offspring.

While rodents offer a rapid feedback loop for gene-editing efficacy, bridging the gap to a six-ton pachyderm demands increasingly sophisticated intermediate models. Colossal has signaled that a woolly pig is next in the experimental pipeline, though executives have withheld a specific timeline for its public debut. These stepping stones build upon the company’s proven genetic engineering milestones, highlighted in the spring of 2025 when Colossal announced it had successfully brought the extinct dire wolf back to life. By collecting ancient DNA from a preserved ear bone and tooth, researchers sequenced the dire wolf genome, made 20 precise edits across 14 genes in gray wolf cells using CRISPR-Cas9, and implanted the resulting embryos into a domestic hound surrogate to successfully produce dire wolf pups within nine weeks.

Despite these remarkable breakthroughs with smaller canids, scaling the process to elephant surrogates involves entirely different physiological and reproductive hurdles. Speaking on the evolving schedule, Colossal CEO and co-founder Ben Lamm noted that target goal posts have shifted outward. As noted in recent reporting by TIME, Lamm stated, We are thinking it will be in the early 2030s. We don’t have a hard date. Not 2036, but not 2030 either.

Cancer Resistance and Broad Genomic Implications

Beyond the primary objective of returning a walking, breathing mammoth to the tundra, the deep genomic mining powering the project has unlocked unexpected avenues for biomedical research. Elephants present a compelling biological paradox: given that an adult elephant’s body contains roughly 100 times more cells than a human body, they should statistically suffer from high rates of cancer. Yet, cancer accounts for less than 5% of elephant mortality, compared to approximately 16% in humans.

Recent genetic mapping attributes this remarkable resistance largely to the TP53 tumor-suppressor gene. While humans carry two copies of TP53, elephants possess 20 copies. When cellular DNA suffers corruption, these genes trigger the release of the p53 protein to either repair the damage or prompt cellular self-destruction. Additionally, elephants carry a unique LIF6 gene that specifically targets and neutralizes the mitochondria of damaged cells before they can divide. Other researchers across the scientific community are actively exploring how these p53 mechanics might be manipulated to bolster human cancer resistance.

To capitalize on these massive datasets, Colossal announced the launch of Astromech, a new enterprise leveraging artificial intelligence and deep learning to trace evolutionary histories, forecast environmental adaptations, and monitor genetic diversity in endangered populations. By deploying Astromech to analyze elephant genomic data alongside ancient mammoth sequences, the research teams aim to unpack cellular mechanisms that extend far beyond paleobiology. As Lamm reflects on the unconventional nature of the work, he observes, It’s a little weird and Frankensteiny, but we’ve done that.

Ultimately, the extended timeline reflects a commitment to biological precision over arbitrary deadlines. While the wait for the first newborn mammoth stretches into the next decade, the foundational science being forged along the way promises to reshape our understanding of mammalian resilience, evolutionary adaptation, and modern biotechnology. Whether watching these genetic milestones unfold fills you with scientific wonder or profound caution, how do you view the ethical boundaries of bringing long-lost species back to life? Let us know your thoughts below.